JAKne? Study of 2183 IBD pts on JAK inhib, 272 developed acne. Crude prevalence: 16% upadacitinib, 4%… Read More
RheumNow
NEW EULAR 2025 POSTER: JAKi safety across ~17,000 patient-years in adults with RA, PsA, AS or nr-axSpA… Read More
Repurposing & Pipeline (8.8.2025) Dr. Jack Cush reviews the news, reports, pipeline and drug repurposing on this… Read More
Chondrocalcinosis Increases Osteoarthritis Risk jjcush@gmail.com Tue, 08/12/2025 – 10:00 Read More
Dermatomyositis Reviewed Researchers from the University of Pennsylvania have published an open-access review of derma https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…… Read More
Mid East/N African Survey on #SpA referrals. – 190 Rheum responded (68% consultants, 53% tertiary,95% urban) –… Read More
Mayo study of 659 incident RA pts finds Multimorbidity predicted 29% (OR:1.29) higher odds of RA flare,… Read More
Rheums Speak: Changing Rheumatology Practices & Choices jjcush@gmail.com Mon, 08/11/2025 – 14:29 Read More
2025 ACR Guidance on Diagnosis and Management of VEXAS jjcush@gmail.com Mon, 08/11/2025 – 14:02 Read More
Inefficiencies of ANA Testing The Journal of Rheumatology has published an analysis of antinuclear antibody (ANA) mult… Read More